LIB Therapeutics and Sun Pharma announce manufacturing agreement for Lerodalcibep, a PCSK9 Inhibitor
Lerodalcibep is approved in the EU under the brand name Lyrokaul for the treatment of adult patients with ...
Research Director, Vyansa Intelligence highlights that the next phase of AI adoption in Indian pharma will depend not on ...
Global pharma major, Lupin announced that it has received tentative approval from the United States Food and Drug Administration (US FDA) for its New Drug Application for Apixaban Oral Suspension […] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results